
|Videos|November 16, 2022
Dr. Goldfischer highlights the value of PSMA-PET imaging in urology
Author(s)Urology Times staff
“PSMA scanning is definitely a game-changer with regard to imaging in advanced prostate cancer in urology,” says Evan R. Goldfischer, MD.
Advertisement
In this interview, Evan R. Goldfischer, MD, MBA, FACS, discusses the value of PSMA-PET imaging in prostate cancer. Goldfischer chaired a discussion on the rapidly emeging modalitiy during the
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Testosterone deficiency: FAQs from the AUA guideline
3
Individualizing androgen pathway therapy in mCSPC
4
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
5












